Inside informationEnglish
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 07/04/2026, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 114296_20260407